Longitudinal transition outcomes among adult dual users of e-cigarettes and cigarettes with the intention to quit in the United States: PaTh Study (2013-2018).
Population Clinical
Cessation
Tobacco
Osibogun (2022)
Evaluation of the Tobacco heating System 2.2. Part 6: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of a mentholated version compared with mentholated and non-mentholated cigarette smoke
Non-Clinical
Safety Effects In Animals
Repeat-dose Toxicity
Oviedo (2016)
adolescent E-cigarette Users at highest Risk of Cigarette Smoking Intention.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Owotomo (2021)
Smoking Intention and Progression From E-Cigarette Use to Cigarette Smoking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Owotomo (2020)
‘The lesser devil you don’t know’: a qualitative study of smokers’ responses to messages communicating comparative risk of electronic and combusted cigarettes.
Population Clinical
Perception Of Risk
Comparison With Tobacco Or Other Nicotine Products
Owusu (2020)
Intrauterine exposure to nicotine through maternal vaping disrupts embryonic lung and skeletal development via the Kcnj2 potassium channel.
Nonclinical
Reproductive &n Developmental Effects
In Vivo
Ozekin (2023)
Electronic Cigarette Terminology: Where Does One Generation End and the Next Begin?
Nonclinical
Ozga (2022)
appeal, subjective effects, and relative reinforcing effects of JUUL that vary in flavor and nicotine content.
Population Clinical
Consumer Use
Reasons For Use
Pacek (2021)
New analytical Method for quantifying Flavoring Chemicals of Potential Respiratory health Risk Concerns in e-Cigarette Liquids.
Nonclinical
Chemical
Methods
Page (2021)
Increases in frequent vaping of cannabis among high school seniors in the United States, 2018–2019.
Population Clinical
Consumer Use
Youth Use & Appeal
Palamar (2021)